Main Page


16.66% 16.66% A COMMITMENT TO EXCELLENCE 16.66% A PASSION TO INNOVATE 16.66%
16.66% SCIENTIFIC CURIOSITY 16.66% INSIGHT AND EXPERTISE 16.66% 16.66%


Definingtheclinicalpathway 71760407.jpg Formerly HCRI, the Baim Institute for Clinical Research is a leading, non-profit academic research organization (ARO) that delivers insight, innovation and leadership in today’s dynamic research environment. We collaborate with the world’s most highly respected researchers from renowned institutions to help advance health and quality of life around the world.


About Our New Name


450+ 50+ 250+ 160K+
STUDIES MANAGED SINCE 1993 FDA SUBMISSIONS PUBLICATIONS ENROLLED SUBJECTS
Services

Featured Studies

Definingtheclinicalpathway 71760407.jpg Healtheconomicsandqualityofllfe 69474500.jpg Dapt study-a.jpg
Defining the Clinical Pathway for the Emerging Valve Space Health Economics and Quality of Life The DAPT Study: A Case Study in Collaboration

Designing and executing a pivotal clinical trial for a small emerging device company.

Many sponsors seeking for approval for innovative, first-in-class medical devices have found that Economic and Quality of Life (EQoL) studies can be a valuable asset in the overall commercialization process.

The Dual Antiplatelet Therapy Study (DAPT) was a landmark clinical trial which we designed and managed, with the objective of determining the appropriate duration of dual antiplatelet therapy following placement of a drug-eluting coronary stent.
MORE DETAILS MORE DETAILS MORE DETAILS


Latest from Baim

Baim Institute Names Dr. C. Michael Gibson As CEO Mordecai Kramer, MBA Chairing ICI17 Panel Dr. Laura Mauri Interview with Circulation

12.05.17

12.01.17

11.28.17
Pioneering Cardiologist Is Also Entrepreneur And Educator Baim Institute's Executive Director of Business Development, Mordecai Kramer, MBA, will be chairing an 8:30 AM panel at ICI Meeting 2017 in Tel Aviv, Israel. The panel title is "Technology Parade I Devices" and is bound to be an interesting discussion. Please see the link below for more information. Dr. Lauri and colleagues, Circulation's Editors, Discuss Late Breaking Science. Start at minute 11 for Dr. Mauri's discussion.
MORE DETAILS MORE DETAILS MORE DETAILS